Wentworth, S., Fiflis, D., Aguiar, J., Brehm, M., Callahan, W., Daci, R., … Sena-Esteves, M. (2025). Exploration of Trans-Splicing Methodologies in AAV Therapeutic Development Targeted at Treating Neurofibromatosis Type-I and Associated Tumors. In MOLECULAR THERAPY (Vol. 33).

Wentworth, Simon, David Fiflis, Julie Aguiar, Michael Brehm, William Callahan, Rrita Daci, Dasha Khvorova-Wolfson, et al. “Exploration of Trans-Splicing Methodologies in AAV Therapeutic Development Targeted at Treating Neurofibromatosis Type-I and Associated Tumors.” In MOLECULAR THERAPY, Vol. 33, 2025.

Wentworth S, Fiflis D, Aguiar J, Brehm M, Callahan W, Daci R, et al. Exploration of Trans-Splicing Methodologies in AAV Therapeutic Development Targeted at Treating Neurofibromatosis Type-I and Associated Tumors. In: MOLECULAR THERAPY. 2025.

Wentworth, Simon, et al. “Exploration of Trans-Splicing Methodologies in AAV Therapeutic Development Targeted at Treating Neurofibromatosis Type-I and Associated Tumors.” MOLECULAR THERAPY, vol. 33, no. 4, 2025.

Wentworth S, Fiflis D, Aguiar J, Brehm M, Callahan W, Daci R, Khvorova-Wolfson D, LaMuragliaa F, Mastroianni S, Mola T, Morales O, Otero M, Scholand A, Uppalapati A, Watson C, Watson M, Asokan A, Batista AR, Sena-Esteves M. Exploration of Trans-Splicing Methodologies in AAV Therapeutic Development Targeted at Treating Neurofibromatosis Type-I and Associated Tumors. MOLECULAR THERAPY. 2025.